Zenas BioPharma (ZBIO) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order at 8:00 A.M. Eastern Time on May 11, 2026, marking the second Annual Meeting as a public company.

• The Chief Legal Officer and Corporate Secretary was introduced to assist with procedural matters.

• Independent Auditors from Ernst & Young LLP and the Inspector of Elections were present to oversee proceedings.

• Stockholders could access the agenda and submit questions via the web portal.

Board and executive committee updates

• Two Class II Directors, James Boylan and Patrick Enright, were nominated for election to serve until the 2029 Annual Meeting.

Shareholder proposals

• No additional proposals were introduced by stockholders as none were submitted in accordance with bylaws.